Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.
about
EGF receptor-targeted nanocarriers for enhanced cancer treatmentChemophototherapy: An Emerging Treatment Option for Solid TumorsTargeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesImpact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.Targeted PDT agent eradicates TrkC expressing tumors via photodynamic therapy (PDT)Urothelial carcinomas: a focus on human epidermal receptors signalingPhotodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response.Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms.Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cellsFluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity.Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity.Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategiesCarboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.Targeted therapies in bladder cancer: an overview of in vivo research.The inhibitory effect of photodynamic therapy and of an anti-VCAM-1 monoclonal antibody on the in vivo growth of C6 glioma xenografts.Photodynamic therapy for malignant pleural mesothelioma: the future of treatment?Expression and function role of DNA methyltransferase 1 in human bladder cancer.Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma
P2860
Q27013001-E39843C4-E303-4C17-B633-CCDC18F587C9Q28468315-F3A4C51B-9FC6-4FEF-AC25-3E4C42CCDF64Q33664307-D484E4CE-DFF6-4ECF-AB5B-D1A912D48515Q34028470-D254EB9E-2648-4E12-8179-DF4D253D7243Q34268784-F96C35C9-E3D0-483E-B947-C38DE101D7FBQ34927053-56BC351A-8229-4384-9FBA-4437DA2EEB89Q35172558-D035D30A-9B0B-4139-8DFA-038C60671759Q35766780-D00A8875-8437-4E77-85D0-4EFB1680E174Q35920966-5FE1FDC8-8051-4B4B-9896-A659CC55F58BQ35955366-B6147F42-BF17-48E6-A44C-0957357F329DQ35973340-0081F27D-A376-4CFB-8A82-F114FF7CD265Q36512623-53683F5E-1CC5-4AA5-B4C0-45EAB3232CA6Q37430574-AF09C665-CE69-4BD6-B8BC-DE5BF84809A4Q38161363-4AA66CD0-ED29-4628-8539-BED7DB68F55DQ38446206-F676A68D-8E84-40CF-AA69-7F0721DF2534Q38590471-E229D7CF-FD8A-43D7-BDFC-641934B1D51CQ39553122-CC87FC75-8DA3-4EC8-8F89-9784770165B9Q39779237-89ED1E7A-3CB6-454F-9849-F058FABAB8FFQ54594046-9A58CF69-2527-462C-A066-CD0184413FE5Q58758069-1B5D8E4A-EC23-4800-B29B-83C6BA4B4F54
P2860
Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Targeting EGFR with photodynam ...... n vivo bladder tumor response.
@en
Targeting EGFR with photodynam ...... n vivo bladder tumor response.
@nl
type
label
Targeting EGFR with photodynam ...... n vivo bladder tumor response.
@en
Targeting EGFR with photodynam ...... n vivo bladder tumor response.
@nl
prefLabel
Targeting EGFR with photodynam ...... n vivo bladder tumor response.
@en
Targeting EGFR with photodynam ...... n vivo bladder tumor response.
@nl
P2093
P2860
P356
P1433
P1476
Targeting EGFR with photodynam ...... n vivo bladder tumor response.
@en
P2093
Khee Chee Soo
Ramaswamy Bhuvaneswari
Yik Yuen Gan
P2860
P2888
P356
10.1186/1476-4598-8-94
P50
P577
2009-11-02T00:00:00Z
P5875
P6179
1020015406